Form 4: Tenet Healthcare CEO Vests RSUs, Sells Shares for Tax
Insider Transaction Report
Tenet Healthcare CEO Saumya Sutaria converted restricted stock units into common stock and subsequently sold shares to cover tax obligations.
Summary
- CEO Saumya Sutaria, a Director and Officer of Tenet Healthcare Corp (THC), vested 53,341 restricted stock units (RSUs) on August 29, 2025.
- These RSUs converted into an equal number of common stock shares.
- Sutaria disposed of 27,087 shares of common stock to cover tax withholding upon the vesting of these restricted stock units.
- An additional 54,174 shares were disposed of to satisfy withholding taxes due upon the vesting of performance share units.
- The shares sold for tax purposes were priced at $184.33 per share, representing the closing price of the common stock on September 29, 2025.
- Following these transactions, Sutaria's direct beneficial ownership of Tenet Healthcare common stock is 447,445 shares.
Sentiment
Score: 7
Explanation: The filing reports routine executive compensation events, including the vesting of restricted stock units and subsequent share sales to cover tax obligations, which are standard practice and do not indicate significant positive or negative operational news.
Positives
- The vesting of 53,341 restricted stock units indicates the achievement of time-based or performance-based milestones by the CEO, reflecting a positive aspect of executive compensation.
Negatives
- The disposition of 81,261 shares (27,087 + 54,174) for tax withholding purposes reduces the CEO's direct beneficial ownership in the company.
Future Outlook
The filing is a transaction report and does not contain forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
This Form 4 filing is a routine disclosure of an insider transaction related to executive compensation and does not provide information directly related to broader industry trends or competitive positioning within the healthcare sector.
Stakeholder Impact
- Shareholders will observe a routine reduction in the CEO's direct beneficial ownership due to tax-related share sales, which is a common occurrence in executive compensation.
Key Dates
| Date | Description |
|---|---|
| 09/01/2021 | Restricted Stock Units (RSUs) were granted pursuant to the 2019 Stock Incentive Plan. |
| 08/29/2025 | Restricted Stock Units vested in full and converted into common stock; shares were disposed of for tax withholding. |
| 09/02/2025 | Date the Form 4 was signed by the reporting person's attorney-in-fact. |
| 09/29/2025 | Closing price of the common stock used for calculating tax withholding on vested units. |
Recommendation
holdThe Form 4 filing details routine executive compensation events, specifically the vesting of restricted stock units and the subsequent sale of shares to cover tax liabilities. These transactions are standard practice and do not provide new material information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation.
Keywords
Tenet Healthcare, THC, Saumya Sutaria, CEO, Director, Form 4, RSU vesting, stock sale, tax withholding, insider transaction, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.